ArticleMolecular therapy. Advances2026

Double activation and low IL-2 manufacturing protocol increase expansion of healthy and patient-derived CAR-Tregs.

Alessia Ugolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.